Schedule 13D ownership disclosure

Cancer Genetics Inc

Security class unavailable · CUSIP: 13739U203

Event date: 2021-02-11

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
0
Percent of class
0.0000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001513162-21-000029
Form type
SC 13D
Filer
Vyant Bio, Inc.
CIK
CIK 1349929
Filed
Feb 25, 2021
Reporting period
Feb 11, 2021
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub